Sorry, mate. Only reading this now.
Yes it does, and most likely the same company it's doing its comparator study against. Read up on Axogen Inc. and specifically Axoguard. They also have their Avance Nerve Graft product (an allograft product), but this still requires the use of their Axoguard (plus sutures) to encompass both ends of the Avance graft attachement.
Their allograft product’s success rate shows a whopping 52.6% – 86% differential between recovery rates. Better than nothing, but hardly spectacular.
- Forums
- ASX - By Stock
- OCC
- Media thread
Media thread, page-550
-
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Add OCC (ASX) to my watchlist
|
|||||
Last
38.5¢ |
Change
-0.005(1.28%) |
Mkt cap ! $80.59M |
Open | High | Low | Value | Volume |
39.0¢ | 39.0¢ | 38.0¢ | $31.21K | 81.11K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 57705 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 1315 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 32705 | 0.370 |
5 | 93663 | 0.365 |
8 | 233743 | 0.360 |
4 | 40833 | 0.355 |
4 | 70714 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 1315 | 1 |
0.395 | 4908 | 1 |
0.400 | 57455 | 4 |
0.405 | 61349 | 3 |
0.410 | 53285 | 4 |
Last trade - 13.37pm 09/08/2024 (20 minute delay) ? |
Featured News
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEWS
Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
OCC (ASX) Chart |